Rachel Fisher

About me
Publications
CV
Public outreach and news

About me

Rachel Fisher was appointed Professor of Cardiovascular Diseases at Karolinska Institutet in 2009. Her research is about the molecular mechanisms behind disturbed lipid metabolism and how this contributes to cardiovascular disease and type 2 diabetes.

Articles

Article: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2023;76:18-26
Capsular inflammation after immediate breast reconstruction-Gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts
Frisell A; Bergman O; Khan A; Gistera A; Fisher RM; Lagergren J; de Boniface J; Halle M
Article: JOURNAL OF PHYSIOLOGY. 2022;600(4):869-883
Hypertrophied human adipocyte spheroids as in vitro model of weight gain and adipose tissue dysfunction
Ioannidou A; Alatar S; Schipper R; Baganha F; Ahlander M; Hornell A; Fisher RM; Hagberg CE
Article: JOURNAL OF LIPID RESEARCH. 2019;60(6):1069-1077
PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells
Taxiarchis A; Mahdessian H; Silveira A; Fisher RM; van't Hooft FM
Article: KIDNEY INTERNATIONAL REPORTS. 2017;2(6):1208-1218
Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney Disease
Gertow J; Ng CZ; Branca RMM; Werngren O; Du L; Kjellqvist S; Hemmingsson P; Bruchfeld A; MacLaughlin H; Eriksson P; Axelsson J; Fisher RM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2016;36(6):1132-1140
Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation
Edsfeldt A; Duner P; Stahlman M; Mollet IG; Asciutto G; Grufman H; Nitulescu M; Persson AF; Fisher RM; Melander O; Orho-Melander M; Boren J; Nilsson J; Goncalves I
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(3):640-648
Psoriasis Skin Inflammation-Induced microRNA-26b Targets NCEH1 in Underlying Subcutaneous Adipose Tissue
Cheung L; Fisher RM; Kuzmina N; Li D; Li X; Werngren O; Blomqvist L; Stahle M; Landen NX
Article: BRITISH JOURNAL OF SPORTS MEDICINE. 2014;48(19):1407-1409
Stand up for health-avoiding sedentary behaviour might lengthen your telomeres: secondary outcomes from a physical activity RCT in older people
Sjogren P; Fisher R; Kallings L; Svenson U; Roos G; Hellenius M-L
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2014;24(2):124-131
Ceramides are associated with inflammatory processes in human mediastinal adipose tissue
Gertow J; Kjellqvist S; Stahlman M; Cheung L; Gottfries J; Werngren O; Boren J; Franco-Cereceda A; Eriksson P; Fisher RM
Article: NUTRITION & DIABETES. 2013;3(5):e66
Human mediastinal adipose tissue displays certain characteristics of brown fat
Cheung L; Gertow J; Werngren O; Folkersen L; Petrovic N; Nedergaard J; Franco-Cereceda A; Eriksson P; Fisher RM
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2013;31(5):1003-1010
MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response
Thulin P; Wei T; Werngren O; Cheung L; Fisher RM; Grander D; Corcoran M; Ehrenborg E
Article: LIPIDS IN HEALTH AND DISEASE. 2012;11:115
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Oresic M; Yki-Jarvinen H; Eriksson P; Fisher RM
Article: LIPIDS IN HEALTH AND DISEASE. 2012;11:80
Functional changes in adipose tissue in a randomised controlled trial of physical activity
Sjogren P; Sierra-Johnson J; Kallings LV; Cederholm T; Kolak M; Halldin M; Brismar K; de Faire U; Hellenius M-L; Fisher RM
Article: THE FASEB JOURNAL. 2010;24(11):4366-4377
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity
Zadravec D; Brolinson A; Fisher RM; Carneheim C; Csikasz RI; Bertrand-Michel J; Boren J; Guillou H; Rudling M; Jacobsson A
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2010;299(2):E234-E240
Systemic inflammation activates the nuclear factor-κB regulatory pathway in adipose tissue
Ekstrom M; Halle M; Bjessmo S; Liska J; Kolak M; Fisher R; Eriksson P; Tornvall P
Article: EUROPEAN HEART JOURNAL. 2010;30(6):710-717
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius M-L; Hamsten A
Article: DIABETOLOGIA. 2009;52(6):1056-1060
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
Kotronen A; Johansson LE; Johansson LM; Roos C; Westerbacka J; Hamsten A; Bergholm R; Arkkila P; Arola J; Kiviluoto T; Fisher RM; Ehrenborg E; Orho-Melander M; Ridderstrale M; Groop L; Yki-Jarvinen H
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2009;160(4):593-602
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts
Kotronen A; Yki-Jarvinen H; Aminoff A; Bergholm R; Pietilainen KH; Westerbacka J; Talmud PJ; Humphries SE; Hamsten A; Isomaa B; Groop L; Orho-Melander M; Ehrenborg E; Fisher RM
Article: CLINICAL SCIENCE. 2009;116(5-6):507-512
IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Malarstig A; Brismar K; Hamsten A; Fisher RM; Hellenius M-L
Article: EUROPEAN HEART JOURNAL. 2008;29(18):2218-2226
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
Sjogren P; Fredrikson GN; Samnegard A; Ericsson C-G; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Article: OBESITY. 2008;16(6):1302-1307
Eating meals irregularly:: A novel environmental risk factor for the metabolic syndrome
Sierra-Johnson J; Unden A-L; Linestrand M; Rosell M; Sjogren P; Kolak M; De Faire U; Fisher RM; Hellenius M-L
Article: AMERICAN JOURNAL OF PHYSIOLOGY - GASTROINTESTINAL AND LIVER PHYSIOLOGY. 2008;294(5):G1281-G1287
Gene expression in human NAFLD
Greco D; Kotronen A; Westerbacka J; Puig O; Arkkila P; Kiviluoto T; Laitinen S; Kolak M; Fisher RM; Hamsten A; Auvinen P; Yki-Jarvinen H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2008;93(5):1995-2001
Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation
Krapivner S; Popov S; Chernogubova E; Hellenius M-L; Fisher RM; Hamsten A; van't Hooft FM
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2008;294(5):E841-E845
Insulin regulation of MCP-1 in human adipose tissue of obese and lean women
Westerbacka J; Corner A; Kolak M; Makkonen J; Turpeinen U; Hamsten A; Fisher RM; Yki-Jarvinen H
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 2008;57(3):362-366
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
Sjogren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius M-L; Fisher RM
Article: DIABETOLOGIA. 2008;51(2):328-335
Fatty acid desaturases in human adipose tissue:: relationships between gene expression, desaturation indexes and insulin resistance
Sjogren P; Sierra-Johnson J; Gertow K; Rosell M; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher RM
Article: ATHEROSCLEROSIS. 2007;195(2):e168-e175
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nε-carboxymethyl-lysine in healthy Swedish men
Sjogren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius M-L; Fisher RM
Article: EUROPEAN HEART JOURNAL. 2007;28(21):2637-2643
ApoB/apoA-1 ratio:: an independent predictor of insulin resistance in US non-diabetic subjects
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellenius M-L; Fisher RM
Article: DIABETES. 2007;56(11):2759-2765
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
Westerbacka J; Kolak M; Kiviluoto T; Arkkila P; Siren J; Hamsten A; Fisher RM; Yki-Jaervinen H
Article: INTERNATIONAL JOURNAL OF OBESITY. 2007;31(10):1617-1625
Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity
Makkonen J; Westerbacka J; Kolak M; Sutinen J; Corner A; Hamsten A; Fisher RM; Yki-Jarvinen H
Article: DIABETES. 2007;56(8):1960-1968
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity
Kolak M; Westerbacka J; Velagapudi VR; Wagsater D; Yetukuri L; Makkonen J; Rissanen A; Hakkinen A-M; Lindell M; Bergholm R; Hamsten A; Eriksson P; Fisher RM; Oresic M; Yki-Jarvinen H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2007;92(2):720-724
Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes
Kolak M; Yki-Jarvinen H; Kannisto K; Tiikkainen M; Hamsten A; Eriksson P; Fisher RM
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2006;60(12):1406-1413
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance
Gertow K; Rosell M; Sjogren P; Eriksson P; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher RM
Article: DIABETOLOGIA. 2006;49(1):132-140
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects
Westerbacka J; Cornér A; Kannisto K; Kolak M; Makkonen J; Korsheninnikova E; Nyman T; Hamsten A; Fisher RM; Yki-Järvinen H
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2005;25(12):2580-2586
Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome
Sjogren P; Basu S; Rosell M; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
Article: DIABETOLOGIA. 2004;47(6):1118-1125
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance
Gertow K; Pietiläinen KH; Yki-Järvinen H; Kaprio J; Rissanen A; Eriksson P; Hamsten A; Fisher RM
Article: AMERICAN JOURNAL OF PHYSIOLOGY - ENDOCRINOLOGY AND METABOLISM. 2004;286(6):E941-E949
Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Article: ENDOCRINOLOGY. 2004;145(4):1972-1979
Female-predominant expression of fatty acid translocase/CD36 in rat and human liver
Ståhlberg N; Rico-Bautista E; Fisher RM; Wu XX; Cheung L; Flores-Morales A; Tybring G; Norstedt G; Tollet-Egnell P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2004;89(1):392-399
Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome
Gertow K; Bellanda M; Eriksson P; Boquist S; Hamsten A; Sunnerhagen M; Fisher RM
Article: AIDS. 2003;17(12):1753-1762
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy
Kannisto K; Sutinen J; Korsheninnikova E; Fisher RM; Ehrenborg E; Gertow K; Virkamäki A; Nyman T; Vidal H; Hamsten A; Yki-Järvinen H
Article: ATHEROSCLEROSIS. 2003;167(2):311-317
Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men
Skoglund-Andersson C; Ehrenborg E; Fisher RM; Olivercrona G; Hamsten A; Karpe F
Article: ATHEROSCLEROSIS. 2003;167(2):265-273
A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution
Gertow K; Skoglund-Andersson C; Eriksson P; Boquist S; Orth-Gomér K; Schenck-Gustafsson K; Hamsten A; Fisher RM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2003;23(4):688-694
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy
Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
Article: ATHEROSCLEROSIS. 2003;166(2):243-251
Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers
Fisher RM; Benhizia F; Schreiber R; Makoveichuk E; Putt W; Al-Haideri M; Deckelbaum RJ; Olivecrona G; Humphries SE; Talmud PJ
Article: MOLECULAR AND CELLULAR BIOCHEMISTRY. 2002;239(1-2):95-100
Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals
Fisher RM; Thörne A; Hamsten A; Arner P
Article: INTERNATIONAL JOURNAL OF OBESITY. 2002;26(10):1379-1385
Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue
Fisher RM; Hoffstedt J; Hotamisligil GS; Thörne A; Rydén M
Article: DIABETOLOGIA. 2001;44(10):1268-1273
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals
Fisher RM; Eriksson P; Hoffstedt J; Hotamisligil GS; Thörne A; Rydén M; Hamsten A; Arner P
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2000;20(12):2663-2669
Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men
Waterworth DM; Talmud PJ; Bujac SR; Fisher RM; Miller GJ; Humphries SE
Article: ATHEROSCLEROSIS. 2000;149(2):387-394
Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat
Wallace AJ; Humphries SE; Fisher RM; Mann JI; Chisholm A; Sutherland WHF
Article: JOURNAL OF LIPID RESEARCH. 1999;40(2):287-294
Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II
Fisher RM; Burke H; Nicaud V; Ehnholm C; Humphries SE
Article: CIRCULATION. 1997;96(3):733-740
Lipoprotein lipase variants D9N and N291S, are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations - Studies in the fasting and postprandial states: The European atherosclerosis research studies
Gerdes C; Fisher RM; Nicaud V; Boer J; Humphries SE; Talmud PJ; Faergeman O
Article: JOURNAL OF LIPID RESEARCH. 1997;38(7):1463-1472
Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol
Syvanne M; Talmud PJ; Humphries SE; Fisher RM; Rosseneu M; Hilden H; Taskinen MR
Article: METABOLISM: CLINICAL AND EXPERIMENTAL. 1997;46(6):605-610
Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue
Fisher RM; Miles JM; Kottke BA; Frayn KN; Coppack SW
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(8):631-639
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia
DeBruin TWA; Mailly F; VanBarlingen HHJJ; Fisher R; Cabezas MC; Talmud P; DallingaThie GM; Humphries SE
Article: CLINICAL SCIENCE. 1996;90(5):409-415
Carbohydrate metabolism in insulin resistance: Glucose uptake and lactate production by adipose and forearm tissues in vivo before and after a mixed meal
Coppack SW; Fisher RM; Humphreys SM; Clark ML; Pointon JJ; Frayn KN
Article: ATHEROSCLEROSIS. 1996;122(1):21-28
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study
Mailly F; Fisher RM; Nicaud V; Luong LA; Evans AE; MarquesVidal P; Luc G; Arveiler D; Bard JM; Poirier O; Talmud PJ; Humphries SE
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1996;270(4):E718-E722
Periprandial systemic and regional lipase activity in normal humans
Coppack SW; Yost TJ; Fisher RM; Eckel RH; Miles JM
Article: JOURNAL OF LIPID RESEARCH. 1995;36(10):2104-2112
INTERACTION OF THE LIPOPROTEIN-LIPASE ASPARAGINE-291-]SERINE MUTATION WITH BODY-MASS INDEX DETERMINES ELEVATED PLASMA TRIACYLGLYCEROL CONCENTRATIONS - A STUDY IN HYPERLIPIDEMIC SUBJECTS, MYOCARDIAL-INFARCTION SURVIVORS, AND HEALTHY-ADULTS
FISHER RM; MAILLY F; PEACOCK RE; HAMSTEN A; SEED M; YUDKIN JS; BEISIEGEL U; FEUSSNER G; MILLER G; HUMPHRIES SE; TALMUD PJ
Article: CLINICA CHIMICA ACTA. 1995;236(1):7-17
HUMAN TRIACYLGLYCEROL-RICH LIPOPROTEIN SUBFRACTIONS AS SUBSTRATES FOR LIPOPROTEIN-LIPASE
FISHER RM; COPPACK SW; HUMPHREYS SM; GIBBONS GF; FRAYN KN
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1995;268(4):E588-E594
IMPAIRED POSTPRANDIAL CLEARANCE OF TRIACYLGLYCEROL-RICH LIPOPROTEINS IN ADIPOSE-TISSUE IN OBESE SUBJECTS
POTTS JL; COPPACK SW; FISHER RM; HUMPHREYS SM; GIBBONS GF; FRAYN KN
Show more

All other publications

Review: OBESITY REVIEWS. 2022;23(4):e13403
The multifaceted roles of the adipose tissue vasculature
Ioannidou A; Fisher RM; Hagberg CE
Preprint: BIORXIV. 2021
Hypertrophied human adipocyte spheroids asin vitromodel of weight gain and adipose tissue dysfunction
Ioannidou A; Alatar S; Åhlander M; Hornell A; Fisher R; Hagberg C
Editorial comment: ATHEROSCLEROSIS. 2013;226(2):510-516
European Lipoprotein Club: Report of the 35th ELC Annual Conference (Tutzing, 10th-13th September 2012)
Costet P; Ehrenborg E; Fisher R; Fielding B; Groen A; Kardassis D; Malle E; Mulder M; Niemeier A; Norata GD; Hansen AT; von Eckardstein A
Other: ATHEROSCLEROSIS. 2012;221(1):287-293
European Lipoprotein Club: Report of the 34th ELC annual conference, Tutzing, 5-8 September 2011.
Bernini F; Costet P; Ehrenborg E; Fisher R; Fielding B; Freeman D; Groen A; Malle E; Mulder M; Niemeier A; Hansen AT; von Eckardstein A
Editorial comment: ATHEROSCLEROSIS. 2011;215(1):249-255
Report of the 33rd Annual Conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010
Bernini F; Fisher R; Freeman D; Groen A; Kalopissis A; Malle E; Mulder M; Niemeier A; Parini P; Hansen AT; von Eckardstein A
Published conference paper: JOURNAL OF CARDIOVASCULAR RISK. 2009;16(1):80-84
Beneficial effects of individualized physical activity on prescription on body composition and cardiometabolic risk factors: results from a randomized controlled trial
Kallings LV; Johnson JS; Fisher RM; de Faire U; Stahle A; Hemmingsson E; Hellenius M-L
Editorial comment: NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE. 2008;5(1):18-19
Is it time to discard the apo B:apo A-I ratio as a predictor of cardiovascular disease?
Sierra-Johnson J; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):39
High apolipoprotein B/apolipoprotein ai ratio is associated with insulin resistance in US non-diabetic subjects
Sierra-Johnson J; Romero-Corral A; Fisher RM; Lopez-Jimenez F; Somers VK
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):116
Endothelial activity is related to diet and components of the metabolic syndrome, but not to advanced glycation end-products in healthy swedish men
Sjogren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):60-61
Human evidence for the involvement of INSIG-2 in the adipose tissue metabolism
Krapivner S; Popov S; Chemogubova E; Hellenius M-L; Fisher R; Hamsten A; van't Hooft F
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):3
Stearoyl coa desaturase (SCD) activity in human adipose tissue is increased in the metabolic syndrome
Fisher RM; Sjogren P; Rose M; Hamsten A; Vessby B; Hellenius M-L
Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2006;26(4):E31-E32
Oxidized LDL and the metabolic syndrome - In response
Sjogren P; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):231
Relationships between autoantibodies against modified LDL and advanced glycation end-products in clinically healthy men
Sjögren P; Fredrikson GN; Basta G; Hamsten A; Nilsson J; Hellenius ML; De Caterina R; Fisher RM
Review: CURRENT OPINION IN LIPIDOLOGY. 2005;16(2):173-178
Fatty acid transport proteins and insulin resistance
Fisher RM; Gertow K
Published conference paper: JOURNAL OF NUTRITION. 2004;134(7):1729-1735
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men
Sjogren P; Rosell M; Skoglund-Andersson C; Zdravkovic S; Vessby B; de Faire U; Hamsten A; Hellenius ML; Fisher RM
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):48-49
Genetic and structural evaluation of fatty acid transport protein-4 (FATP4) in relation to markers of the insulin resistance syndrome
Gertow K; Bellanda M; Sunnerhagen M; Eriksson P; Boquist S; Hamsten A; Fisher R
Review: ATHEROSCLEROSIS. 1997;135(2):145-159
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis
Fisher RM; Humphries SE; Talmud PJ

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI